CHRONOS TECHNOLOGY LIMITED
Company number 02056049 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: CHRONOS TECHNOLOGY LIMITED
1. Financial Health Score: B+
Explanation: Chronos Technology Limited is in robust financial health, exhibiting a strong liquidity position and an excellent cash recovery in the latest fiscal year. The grade of B+ reflects a stable, cash-rich business that has successfully navigated a period of declining net assets (2020-2024) and executed a strategic acquisition. The slight deduction from an A grade is due to a significant increase in current liabilities that warrants monitoring, and the inherent integration risks associated with the recent acquisition.
2. Key Vital Signs
- Blood Pressure (Liquidity): Current Ratio of 1.46:1 — With current assets of £3.02m against current liabilities of £2.07m, the company's financial blood pressure is healthy. They have more than enough liquid resources to cover short-term obligations without breaking a sweat.
- Oxygen Levels (Cash Reserves): £1.89m — Cash levels have surged by nearly 89% from £1m in 2024 to £1.89m in 2025. This indicates excellent "oxygenation," meaning the business can comfortably fund its operations and weather any unexpected shocks.
- Circulation (Debtors Management): Debtors reduced from £1.25m to £0.79m — The company has dramatically improved its cash circulation. By collecting debts more efficiently, they have converted owed money into cash in the bank, a sign of strong financial fitness.
- Muscle Mass (Net Assets): £2.3m — After a period of shrinking net assets (falling from £3.73m in 2020 to £1.95m in 2024), the business has rebuilt its muscle mass to £2.3m. This provides a solid buffer against future financial illness.
- Weight Fluctuation (Employee Count): Reduced from 40 to 36 — A slight reduction in headcount could indicate a leaner, more efficient operational structure, or the completion of a specific project phase.
3. Diagnosis
Overall Condition: Stable and Recovering, with Recent "Surgical" Intervention
The financial data reveals a business that has successfully arrested a period of declining equity. Between 2020 and 2024, the company experienced a steady drain on its net assets (dropping from £3.73m to £1.95m). However, 2025 marks a positive turning point, with net assets growing to £2.3m.
The most significant symptom in the 2025 accounts is the appearance of Goodwill (£343,340). This is the financial equivalent of a major organ transplant—the business has acquired another entity. This acquisition explains the sudden increase in total assets and the corresponding jump in current liabilities (from £1.55m to £2.07m). The increase in liabilities is likely a combination of deferred consideration for the acquisition and the consolidation of the acquired company's own short-term debts.
The balance sheet also benefits from a "supplement" in the form of a Revaluation Reserve (£423,087), representing unrealized gains on property. This acts as a healthy financial vitamin, boosting total equity beyond retained profits. The P&L reserve stands at a healthy £1.83m, proving the company's core operations are profitable.
4. Recommendations
- Post-Acquisition Monitoring (Watch for "Transplant Rejection"): The newly acquired goodwill (£343k) must be carefully monitored for impairment. If the acquired business underperforms, this asset may need to be written down, which would directly impact the P&L and erode shareholder funds. Ensure integration is seamless and synergies are realized.
- Investigate Current Liabilities: The jump in current liabilities to over £2m needs a precise diagnosis. Management must ensure that short-term debts are manageable and that the acquisition has not overloaded the company's short-term payment schedule. If a large portion is deferred consideration, ensure cash is earmarked for this payment.
- Strategic Cash Deployment: With nearly £1.9m sitting in cash, the business has more than enough "fluids" on hand. Consider whether holding this level of cash is the most efficient use of capital. Options include distributing excess cash to shareholders (the Curry family), investing in R&D (as noted in their accounting policies), or paying down short-term liabilities to improve the current ratio further.
- Maintain Debtor Discipline: The improvement in debtor collection is a positive habit. Continue enforcing strict credit control to ensure cash continues to flow efficiently through the system.